AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
Publisher
AbbVie News
Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.
Canonical metadata stays public, while full text remains on the original site.